Inhibition of platelet and neutrophil phospholipase A2 by hydroxyeicosatetraenoic acids (HETEs) A novel pharmacological mechanism for regulating free fatty acid release
- 1 May 1985
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 34 (9), 1571-1575
- https://doi.org/10.1016/0006-2952(85)90701-4
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Characteristics of leukotriene (LT) and hydroxy eicosatetraenoic acid (HETE) synthesis in human leukocytes
- New concepts in the modulation of leukotriene synthesisBiochemical Pharmacology, 1983
- Regulation of leukocyte and platelet lipoxygenases by hydroxyeicosanoidsBiochemical Pharmacology, 1982
- Phospholipid Metabolism in Stimulated Human PlateletsJCI Insight, 1980
- Effects of low doses of thrombin on human platelet phospholipidsThrombosis Research, 1980
- Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generationNature, 1979
- Mobilization of arachidonic acid in human platelets kinetics and Ca2+ dependencyBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1977
- Selective release of archidonic acid from the phospholipids of human platelets in response to thrombin.JCI Insight, 1977
- A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregationProstaglandins, 1976
- Metabolism of [14C]arachidonic acid by human plateletsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1976